← Back to Analyst Consensus 
MRKR Buy
Marker Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Dec 8, 2025 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Apr 1, 2025 | WBB Securities | reiterate | Strong Buy → Strong Buy | $12.5 | — |
| Mar 5, 2025 | Canaccord Genuity | initiate | — → Buy | $8 | 48% |
| Apr 30, 2024 | Ladenburg Thalmann | initiate | — → Buy | $11 | 45% |
Price Target Trend
Apr 24, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days